Search

everythinglearnresearchcommunity

for

Search:↓

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

The new assay can help develop products for hair re-growth.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Niosomal cetirizine shows promise for better alopecia treatment by targeting hair follicles effectively.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Targeting hair follicles can improve skin treatments and reduce side effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.